References
- Statistics of Taiwan Nosocomial Infection Surveillance ReportCenters for Disease Control, Ministry of Health and WelfareTaiwan2016 Available from: https://www.syndriver.com/portal/#/sharing/d1b39e56648849f898802e0c01259a17Accessed March 8, 2018
- BaddourLMWilsonWRBayerASInfective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart AssociationCirculation2015321514351486
- HabibGLancellottiPAntunesMJ2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM)Eur Heart J201536443075312826320109
- ChuangYCLinHYChenPYLinCYWangJTChangSCDaptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin doseClin Microbiol Infect201610890.e1890.e7
- Durante-MangoniEAndiniRParrellaASafety of treatment with high-dose daptomycin in 102 patients with infective endocarditisInt J Antimicrob Agents2016481616827259674
- LaiCCShengWHWangJTSafety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infectionsJ Microbiol Immunol Infect2012451525722153759
- KullarRMcClellanIGeriakMSakoulasGEfficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysisPharmacotherapy201434658258924658897
- MoisePAAmodio-GrotonMRashidMMulticenter evaluation of the clinical outcomes of daptomycin with and without concomitant beta-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairmentAntimicrob Agents Chemother20135731192120023254428
- Cubicin® (daptomycin for injection): US [prescribing information]Lexington, MACubist Pharmaceuticals Inc2007
- CockcroftDWGaultMHPrediction of creatinine clearance from serum creatinineNephron197616131411244564
- MuellerBACromptonJADonovanBJYankalevSLampKCSafety of daptomycin in patients receiving hemodialysisPharmacotherapy201131766567221923453
- HaseldenMLeachMBohmNDaptomycin dosing strategies in patients receiving thrice-weekly intermittent hemodialysisAnn Pharmacother201347101342134724259698
- GouldIMMiroJMRybakMJDaptomycin: the role of high-dose and combination therapy for Gram-positive infectionsInt J Antimicrob Agents201342320221023845504
- HairPIKeamSJDaptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemiaDrugs200767101483151217600394
- BhavnaniSMRubinoCMAmbrosePGDrusanoGLDaptomycin exposure and the probability of elevations in the creatine phosphokinase level: data from a randomized trial of patients with bacteremia and endocarditisClin Infect Dis201050121568157420462352
- SeatonRAGonzalez-RuizAClevelandKOCouchKAPathanRHamedKReal-world daptomycin use across wide geographical regions: results from a pooled analysis of CORE and EU-COREAnn Clin Microbiol Antimicrob2016151826976128
- RhodesAEvansLEAlhazzaniWSurviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Med201743330437728101605
- ErbCTPatelBOrrJEManagement of adults with hospital-acquired and ventilator-associated pneumoniaAnn Am Thorac Soc201631222582260
- BookstaverPBBlandCMQureshiZPSERGE-45 InvestigatorsSafety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United StatesPharmacotherapy201333121322133023712701
- PolsoAKLassiterJLNagelJLImpact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature reviewJ Clin Pharm Ther201439658460825203631